A detailed history of Charles Schwab Investment Management Inc transactions in Veru Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 310,246 shares of VERU stock, worth $235,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
310,246
Holding current value
$235,786
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.76 - $1.79 $235,786 - $555,340
310,246 New
310,246 $260,000
Q2 2023

Aug 09, 2023

SELL
$0.98 - $1.49 $79,548 - $120,946
-81,172 Reduced 21.1%
303,509 $361,000
Q1 2023

May 11, 2023

SELL
$1.16 - $6.41 $36,385 - $201,062
-31,367 Reduced 7.54%
384,681 $446,000
Q4 2022

Feb 13, 2023

BUY
$4.78 - $15.01 $46,040 - $144,576
9,632 Added 2.37%
416,048 $2.2 Million
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $2.43 Million - $5.63 Million
237,706 Added 140.9%
406,416 $4.68 Million
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $13,850 - $50,466
3,184 Added 1.92%
168,710 $1.91 Million
Q1 2022

May 13, 2022

BUY
$4.55 - $6.41 $25,038 - $35,274
5,503 Added 3.44%
165,526 $800,000
Q4 2021

Feb 11, 2022

SELL
$5.89 - $9.73 $3,863 - $6,382
-656 Reduced 0.41%
160,023 $943,000
Q3 2021

Nov 16, 2021

BUY
$6.78 - $9.89 $28,801 - $42,012
4,248 Added 2.72%
160,679 $1.37 Million
Q2 2021

Aug 16, 2021

BUY
$7.24 - $11.2 $126,185 - $195,204
17,429 Added 12.54%
156,431 $1.26 Million
Q1 2021

May 17, 2021

BUY
$8.05 - $20.78 $69,898 - $180,432
8,683 Added 6.66%
139,002 $1.5 Million
Q4 2020

Feb 16, 2021

BUY
$2.36 - $9.99 $19,229 - $81,398
8,148 Added 6.67%
130,319 $1.13 Million
Q2 2020

Aug 14, 2020

BUY
$3.01 - $4.02 $321,982 - $430,023
106,971 Added 703.76%
122,171 $409,000
Q1 2020

May 15, 2020

BUY
$2.58 - $4.58 $39,216 - $69,616
15,200 New
15,200 $50,000
Q2 2019

Aug 09, 2019

SELL
$1.26 - $2.14 $40,721 - $69,162
-32,319 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$1.2 - $1.59 $38,782 - $51,387
32,319 New
32,319 $48,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $60.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.